Balkees Abderrahman

Balkees Abderrahman, M.D., Ph.D., is Forbes 30 Under 30, the DFW Living Legend Scholar of Cancer Research at the Department of Breast Medical Oncology, the University of Texas MD Anderson Cancer Center (TX, USA). She is author of “Hormones and Cancer, Oxford Textbook of Cancer Biology 2019”, “First Targeted Therapy — History of Tamoxifen, Estrogen Receptor and Breast Cancer, Cancer Drug Discovery and Development, Springer Nature 2019”, “Selective Estrogen Receptor Modulators (SERMs), Estrogen Receptor and Breast Cancer, Cancer Drug Discovery and Development, Springer Nature 2019”, and “Steroid Receptors in Breast Cancer, The Breast: Comprehensive Management of Benign and Malignant Diseases 2018”. Abderrahman is a contributor at “Science”, “Nature”, “JAMA Oncology”, “ASCO Post”, “The Pharmaceutical Journal: the UK Royal Pharmaceutical Society Official Journal”, “Cancerworld: the European School of Oncology Official Magazine”, “The Hill”, “The Huffington Post”, “US News and World Report”, “The Nation”, and “The Independent”. She is a published cancer researcher with a bibliography of more than 40 peer-reviewed publications, and an invited reviewer by several journals including the Journal of the National Cancer Institute (JNCI). Finally, Abderrahman was a finalist for the Rolex Award for Enterprise that recognizes: “Exceptional individuals around the world, who are responding to major challenges with original, innovative, and extraordinary projects that advance human knowledge and well-being.”, and the Outstanding Youth Award at the United Nations from over 86 countries for: “Her outstanding work in tackling some of our greatest social, economic, and environmental challenges”. To learn more about Balkees, visit her Linkedin page or follow her on twitter @Balkees_Abd